A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases
Clinical trial NCT05620914 · WITHDRAWN
Trial details
- NCT number
- NCT05620914
- Sponsor
- Mustafa Khasraw, MBChB, MD, FRCP, FRACP
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2026-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.